RJA
ZURA icon

Raymond James & Associates’s Zura Bio ZURA Stock Holding History

Raymond James & Associates’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$697K Buy
171,708
+16,218
+10% +$60.6K ﹤0.01% 2908
2024
Q2 		$544K Buy
155,490
+44,143
+40% +$180K ﹤0.01% 3023
2024
Q1 		$286K Buy
111,347
+33,452
+43% +$119K ﹤0.01% 3396
2023
Q4 		$364K Buy
77,895
+539
+0.7% +$2.69K ﹤0.01% 3155
2023
Q3 		$511K Buy
77,356
+9,481
+14% +$63.4K ﹤0.01% 2881
2023
Q2 		$557K Buy
+67,875
New +$545K ﹤0.01% 2867

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Raymond James & Associates's ZURA Position: Q3 2024 in Review

Raymond James & Associates increased its Zura Bio (ZURA) stake by 10% in Q3 2024, buying an estimated $60.6K and bringing the position to 171,708 shares worth $697K. The position accounts for ﹤0.01% of the portfolio, ranked #2908.

Raymond James & Associates first reported a position in ZURA in Q2 2023 and has held it in 6 quarters since. 78 funds tracked by Wall St. Rank hold ZURA as of Q3 2024.

  • Raymond James & Associates held 171,708 shares of Zura Bio worth $697K as of Q3 2024.
  • Raymond James & Associates bought 16,218 Zura Bio shares in Q3 2024, an estimated $60.6K.
  • Zura Bio made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2908 holding.
  • Raymond James & Associates first reported a position in Zura Bio in Q2 2023 and has held it in 6 quarters since.
  • 78 funds tracked by Wall St. Rank held Zura Bio as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.